Population pharmacokinetics of isoniazid in the treatment of Mycobacterium tuberculosis among Asian and African elephants (Elephas maximus and Loxodonta africana)

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 1, 2005, Pages 21-27

  Maslow, Joel N ^a,h   Mikota, S K ^b   Zhu, M ^c   Isaza, R ^d   Peddie, L R ^e   Dunker, F ^e   Peddie, J ^e   Riddle, H ^f   Peloquin, C A ^c,g  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Mimosa Court   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d University of Florida College of Veterinary Medicine   (United States)

^e Riddle Elephant and Wildl Sanctuary ^*  (United States)

^f Riddle Elephant and Wildlife Sanctuary   (United States)

^g UNIVERSITY OF COLORADO   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADOLESCENT; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG EXPOSURE; DRUG FORMULATION; ELEPHANT; ELEPHAS MAXIMUS; FEMALE; FOOD DRUG INTERACTION; LOXODONTA AFRICANA; MALE; MAXIMUM PLASMA CONCENTRATION; MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NONLINEAR MIXED EFFECT MODEL; PHARMACOKINETICS; POPULATION PHARMACOKINETICS; POPULATION RESEARCH; POWDER; PRIORITY JOURNAL; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION; TUBERCULOSIS;

ADMINISTRATION, ORAL; ADMINISTRATION, RECTAL; ANIMALS; ANTITUBERCULAR AGENTS; AREA UNDER CURVE; ELEPHANTS; FEMALE; ISONIAZID; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

ELEPHANTIDAE; ELEPHAS MAXIMUS; LOXODONTA AFRICANA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 14844367072     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2004.00619.x     Document Type: Article

References (19)

1. Burman, W.J. (1997) The value of in-vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: a critical review. American Journal of the Medical Sciences, 313, 355-363.
2. Damman, D. & Stedefeder, H. (1909) Tuberkulöse Erkrankung eines Elefanten, hervorgerufen durch Bazillen des sogenannten typus humanus. Deutsche Tierärztliche Wochenschrift. 17, 345-346.
3. Devine, J.E., Boever, W.J. & Miller, E. (1983) Isoniazid therapy in an Asiatic elephant (Elephas maximus). Journal of Zoo and Animal Medicine, 14, 130-133.
4. Frankel, D.H. (1997) Elephants pack their trunk and leave the circus. Lancet. 349, 1675.
5. Greenberg, H.B., Jung, R.C. & Gutter, A.E. (1981) Hazel elephant is dead (of tuberculosis). The American Review of Respiratory Disease. 124, 341.
6. Iyer, A.K. (1937) Veterinary science in India. ancient and modern with special reference to tuberculosis. Agriculture and Live-stock in India. 7, 718-724.
7. McGaughey, C.A. (1961) Diseases of elephants: part III. Ceylon Veterinary Journal. 9, 94-98.
8. Mikota, S.K. & Maslow, J.N. (1997) Theoretical and technical aspects of diagnostic techniques for mammalian tuberculosis. In Annual Conference of the American Association of Zoo Veterinarians. Ed. Baer. C.K. pp. 162-165. Houston. TX. USA.
9. Mikota, S.K., Larsen, R.S. & Montali, R.J. (2000) Tuberculosis in elephants in North America. Zoo Biology. 19, 393-403.
10. Mikota, S.K., Peddie, L., Peddle, J. et al. (2001) Epidemiology and diagnosis of Mycobacterium tuberculosis in captive Asian elephants (Elephas maximus). Journal of Zoo and Wildlife Medicine. 32, 1-16.
11. Peloquin, C.A. (1997) Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clinics in Chest Medicine, 18, 79-87.
12. Peloquin, C.A. (2003) Clinical pharmacology of anti-tuberculous drugs. In Clinical Tuberculosis. Ed. Davies. P.D.O. pp. 171-190. Arnold Publishers. London. England.
13. Peloquin, C.A., Jaresko, G.S., Yong, C.L., Keung, A.C.F., Bulpitt, A.E. & Jeliffe, R.W. (1997) Population pharmacokinetic modeling of isoniazid. rifampin, and pyrazinamide. Antimicrobial Agents and Chemotherapy, 41, 2670-2679.
14. Peloquin, C.A., Namdar, R., Dodge, A.A. & Nix, D.E. (1999) Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids. International Journal of Tuberculosis and Lung Disease. 3, 703-710.
15. Pinto, M.R.M., Jainudeen, M.R. & Panabokke, R.G. (1973) Tuberculosis in a domesticated asiatic elephant Elephas maximus. Veterinary Record. 93, 662-664.
16. Saunders, G. (1983) Pulmonary Mycobacterhim tuberculosis infection in a circus elephant. Journal of the American Veterinary Medical Association. 183, 1311-1312.
17. Sved, S., McGilveray, I. & Beaudoin, N. (1977) Bioavailability of three isoniazid formulations. Journal of Pharmaceutical Science, 66, 1761-1764.
18. United States Department of Agriculture (1998) United States Department of Agriculture. Animal and Plant Health Inspection Service. Animal Care Policies. Policy #21: Guidelines for the control of tuberculosis in elephants. From the National Tuberculosis Working Group for Zoo and Wildlife Species. Available from: http://www.aphis.usda. gov/ac/policy/policy21.pdf [accessed 11 February 2005].
19. Weiner, M., Burman, W., Vernon, A., Benator, D., Peloquin, C.A., Khan, A., Weis, S., King, B., Shah, N., Hodge, T. & the Tuberculosis Trials Consortium. (2003) Low isoniazid concentration associated with outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. American Journal of Respiratory and Critical Care Medicine. 167, 1341-1347.